Therapeutic Drug Monitoring of Linezolid in Drug-Resistant Tuberculosis Patients: Clinical Factors and Hematological Toxicities.
Junjie ChengYuan YuanJinmeng LiRuoying ZhangXudong FanZhirou XuHuirong LinXinjun CaiMingfeng ZhengPublished in: Infection and drug resistance (2024)
is imperative during anti-DR-TB therapy to tailor treatment and mitigate hematological toxicity.
Keyphrases
- drug resistant
- end stage renal disease
- multidrug resistant
- mycobacterium tuberculosis
- acinetobacter baumannii
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- stem cells
- oxidative stress
- emergency department
- pulmonary tuberculosis
- bone marrow
- hiv infected
- combination therapy
- pseudomonas aeruginosa
- patient reported
- cell therapy
- electronic health record